GLIDAPA BISO

GLIDAPA BISO is a combination medication formulated with two active ingredients: Dapagliflozin (10 mg) and Bisoprolol Fumarate (5 mg). This dual-action therapy is used primarily for the management of type 2 diabetes and hypertension. Dapagliflozin is a SGLT2 inhibitor that helps lower blood sugar levels by promoting the excretion of glucose through urine, while Bisoprolol is a beta-blocker that effectively reduces blood pressure and heart rate, providing comprehensive cardiovascular benefits. Together, these medications help in the effective control of blood sugar and blood pressure, reducing the risk of complications related to diabetes and hypertension.

Key Benefits:

• Helps Lower Blood Sugar Levels: Dapagliflozin works by eliminating excess glucose through urine, improving glycemic control in patients with type 2 diabetes.

• Reduces Blood Pressure: Bisoprolol effectively lowers blood pressure by slowing the heart rate and reducing the heart's workload, which is essential for managing hypertension and preventing heart complications.

• Improves Cardiovascular Health: The combination of these two medications supports heart health, particularly in people with both diabetes and hypertension.

• Convenient Dual Therapy: By combining two medications into one tablet, GLIDAPA BISO offers a simplified treatment regimen, improving medication adherence.

• Helps Prevent Cardiovascular Complications: Both components of GLIDAPA BISO have protective effects on the heart, helping to reduce the risk of stroke, heart attack, and kidney disease in patients with diabetes and hypertension.

How Does It Work?

Dapagliflozin, as an SGLT2 inhibitor, blocks the sodium-glucose cotransporter-2 in the kidneys, reducing glucose reabsorption and facilitating its excretion through urine. This lowers blood sugar levels, providing effective control of type 2 diabetes.

Bisoprolol Fumarate, a beta-blocker, works by selectively blocking beta-1 adrenergic receptors in the heart. This reduces the heart rate and the force of contraction, leading to a reduction in blood pressure and decreasing the heart's demand for oxygen, which helps in managing hypertension and preventing cardiovascular events like heart failure or strokes.

Together, the two active ingredients target multiple aspects of cardiovascular health, providing effective management of both blood sugar and blood pressure, which is crucial for patients with diabetes and hypertension.

Directions for Use:

• Dosage: The typical dosage of GLIDAPA BISO is one tablet once daily, as prescribed by your healthcare provider. It is recommended to take the tablet in the morning with or without food.

• Administration: Swallow the tablet whole with a glass of water. Do not chew, crush, or break the tablet.

• Consistency: Take the medication at the same time every day to help remember your dose.

• Adjustments: Your doctor may adjust the dose based on your individual health needs and response to treatment.

• Lifestyle: Along with taking this medication, following a healthy diet and exercise plan is crucial for optimal management of diabetes and hypertension.

Side Effects:

While GLIDAPA BISO is generally well-tolerated, some patients may experience side effects, including:

• Dapagliflozin Side Effects:

  • Urinary tract infections (UTIs)

  • Increased urination

  • Dehydration or dizziness

  • Low blood pressure

  • Increased thirst

  • Yeast infections (in both men and women)

• Bisoprolol Side Effects:

  • Fatigue or weakness

  • Dizziness or lightheadedness

  • Slow heart rate

  • Cold hands or feet

  • Shortness of breath (rare)

  • Low blood pressure (hypotension)